中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2015年
1期
72-77
,共6页
刘洋%贾德进%闫俊灵%李梁%陈冲%王程%丁红%汤苏阳
劉洋%賈德進%閆俊靈%李樑%陳遲%王程%丁紅%湯囌暘
류양%가덕진%염준령%리량%진충%왕정%정홍%탕소양
干细胞%移植%自体脂肪间充质干细胞%鼻黏膜%修复重建%组织细胞移植%间充质干细胞%鼻黏膜瘢痕%鼻黏膜溃疡%鼻腔容积%最小横断面积%鼻黏膜纤毛清除功能
榦細胞%移植%自體脂肪間充質榦細胞%鼻黏膜%脩複重建%組織細胞移植%間充質榦細胞%鼻黏膜瘢痕%鼻黏膜潰瘍%鼻腔容積%最小橫斷麵積%鼻黏膜纖毛清除功能
간세포%이식%자체지방간충질간세포%비점막%수복중건%조직세포이식%간충질간세포%비점막반흔%비점막궤양%비강용적%최소횡단면적%비점막섬모청제공능
Stem Cells%Adipose Tissue%Nasal Mucosa%Mucociliary Clearance
背景:体外扩增的自体脂肪来源干细胞具有多向分化的潜能,在组织工程和再生医学领域具有广阔的应用前景。目的:观察自体脂肪来源干细胞移植受损人鼻黏膜组织的结构和功能变化。方法:选取因物理或化学因素造成鼻黏膜损害的患者10例,其中6例黏膜瘢痕,4例黏膜破溃,抽取自体脂肪组织进行脂肪来源干细胞体外分离、培养、扩增,移植前进行质量安全性检测。6例患者在黏膜瘢痕基底部、4例患者在黏膜破溃处注射移植脂肪来源干细胞(1×107/cm2结果与结论:脂肪来源干细胞注射移植后,所有患者临床症状得到缓解。与移植前比较,脂肪来源干细胞注射移植后30,90,150 d鼻腔容积及鼻腔最小横断面积有所减少(P <0.05),鼻黏膜纤毛清除功能有所改善,但差异无显著性意义(P >0.05)。与移植前相比,脂肪来源干细胞移植30 d时3例患者鼻黏膜炎症明显减轻,胶原纤维排列整齐、沉积减少,杯状细胞分泌的黏蛋白增多。结果证明了体外扩增的脂肪来源干细胞可以重建鼻黏膜结构和恢复其功能。),共注射3次,每2次间隔15 d。末次注射移植后30,90,150 d分别行鼻腔容积、最小横断面积、黏膜纤毛清除功能测定,其中3例患者在移植前和移植后30 d,取0.1 cm×0.1 cm黏膜组织,进行苏木精-伊红染色、Masson三色染色、AB-PAS染色。
揹景:體外擴增的自體脂肪來源榦細胞具有多嚮分化的潛能,在組織工程和再生醫學領域具有廣闊的應用前景。目的:觀察自體脂肪來源榦細胞移植受損人鼻黏膜組織的結構和功能變化。方法:選取因物理或化學因素造成鼻黏膜損害的患者10例,其中6例黏膜瘢痕,4例黏膜破潰,抽取自體脂肪組織進行脂肪來源榦細胞體外分離、培養、擴增,移植前進行質量安全性檢測。6例患者在黏膜瘢痕基底部、4例患者在黏膜破潰處註射移植脂肪來源榦細胞(1×107/cm2結果與結論:脂肪來源榦細胞註射移植後,所有患者臨床癥狀得到緩解。與移植前比較,脂肪來源榦細胞註射移植後30,90,150 d鼻腔容積及鼻腔最小橫斷麵積有所減少(P <0.05),鼻黏膜纖毛清除功能有所改善,但差異無顯著性意義(P >0.05)。與移植前相比,脂肪來源榦細胞移植30 d時3例患者鼻黏膜炎癥明顯減輕,膠原纖維排列整齊、沉積減少,杯狀細胞分泌的黏蛋白增多。結果證明瞭體外擴增的脂肪來源榦細胞可以重建鼻黏膜結構和恢複其功能。),共註射3次,每2次間隔15 d。末次註射移植後30,90,150 d分彆行鼻腔容積、最小橫斷麵積、黏膜纖毛清除功能測定,其中3例患者在移植前和移植後30 d,取0.1 cm×0.1 cm黏膜組織,進行囌木精-伊紅染色、Masson三色染色、AB-PAS染色。
배경:체외확증적자체지방래원간세포구유다향분화적잠능,재조직공정화재생의학영역구유엄활적응용전경。목적:관찰자체지방래원간세포이식수손인비점막조직적결구화공능변화。방법:선취인물리혹화학인소조성비점막손해적환자10례,기중6례점막반흔,4례점막파궤,추취자체지방조직진행지방래원간세포체외분리、배양、확증,이식전진행질량안전성검측。6례환자재점막반흔기저부、4례환자재점막파궤처주사이식지방래원간세포(1×107/cm2결과여결론:지방래원간세포주사이식후,소유환자림상증상득도완해。여이식전비교,지방래원간세포주사이식후30,90,150 d비강용적급비강최소횡단면적유소감소(P <0.05),비점막섬모청제공능유소개선,단차이무현저성의의(P >0.05)。여이식전상비,지방래원간세포이식30 d시3례환자비점막염증명현감경,효원섬유배렬정제、침적감소,배상세포분비적점단백증다。결과증명료체외확증적지방래원간세포가이중건비점막결구화회복기공능。),공주사3차,매2차간격15 d。말차주사이식후30,90,150 d분별행비강용적、최소횡단면적、점막섬모청제공능측정,기중3례환자재이식전화이식후30 d,취0.1 cm×0.1 cm점막조직,진행소목정-이홍염색、Masson삼색염색、AB-PAS염색。
BACKGROUND:Theex-vivo expanded autologous adipose-derived stem cels have the capability of multipotential differentiation and have a broad application prospect in the field of tissue engineering and regenerative medicine. OBJECTIVE:To observe the nasal mucosal structural repair and functional reconstruction usingex-vivo expanded autologous adipose-derived stem cels. METHODS:Ten patients with mucosal damage due to the physical or chemical factors were enroled, including six cases of mucosal scar and four cases of mucosal ulceration. Autologous adipose tissue was extracted forin vitro isolation, culture and expansion of adipose-derived stem cels. Before transplantation, quality safety testing was done. Al the patients were injected adipose-derived stem cels (1×107/cm2 0.1 cm mucosal tissue sample at 30 days before and after transplantation for hematoxylin-eosin staining, Masson ) at an interval of 15 days, totaly for three times. Nasal volume, minimum cross-sectional area, and mucociliary clearance function were determined at 30, 90, 150 days after the final injection. Three of 10 patients were selected to take a 0.1 cm× trichrome staining, and AB-PAS staining. RESULTS AND CONCLUSION:Clinical symptoms were aleviated in al patients undergoing transplantation of adipose-derived stem cels. Compared with the baseline data, the nasal volume and minimum cross-sectional area were both decreased at 30, 90, 150 days after transplantation (P < 0.05), and the mucociliary clearance function was improved but not significantly (P > 0.05). Compared with the baseline data, the inflammation of the nasal mucosa was significantly reduced, colagen fibers arranged neatly, the deposition was decreased, and mucin secreted from goblet cels was increased in the selected three patients at 30 days after cel transplantation. These findings indicate thatex-vivo expanded autologous adipose-derived stem cels can be used to reconstruct the nasal mucosal structure and its function.